It was later discovered that one of the donors was HIV positive, leading to her infection..HIV, AIDS, Cancer patient, RCC, Kerala High Court ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Prof. Francisca Mutapi, a global health expert suggests 4 ways to end the dependence HEALTH | FRANCISCA MUTAPI | There’s been a global trend in the reduction of aid to Africa since 2018. Donors are ...

Malawians must brace for more tough times following the United Sates of America’s (USA) decision to terminate contracts worth ...

Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

A study presented at CROI 2025 reveals that a single-question self-efficacy measure effectively predicts ART adherence and viral load suppression among pregnant women with HIV in Malawi, offering a ...

A new study in Australia found that treating male partners can reduce BV reinfections, suggesting that BV may be sexually ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...